Caribou Biosciences (CRBU) Short Interest Ratio & Short Volume → 25% of Americans Are In Grave Danger (From Banyan Hill Publishing) (Ad) Free CRBU Stock Alerts $1.95 -0.14 (-6.70%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Caribou Biosciences Short Interest DataCurrent Short Interest10,490,000 sharesPrevious Short Interest10,640,000 sharesChange Vs. Previous Month-1.41%Dollar Volume Sold Short$38.18 millionShort Interest Ratio5.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares90,320,000 sharesFloat Size79,880,000 sharesShort Percent of Float13.13%Today's Trading Volume2,014,016 sharesAverage Trading Volume2,762,329 sharesToday's Volume Vs. Average73% Short Selling Caribou Biosciences ? Sign up to receive the latest short interest report for Caribou Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRBU Short Interest Over TimeCRBU Days to Cover Over TimeCRBU Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself Caribou Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202410,490,000 shares $38.18 million -1.4%13.1%5.6 $3.64 4/30/202410,640,000 shares $38.62 million -6.2%13.4%6.6 $3.63 4/15/202411,340,000 shares $46.15 million +11.2%14.2%7.1 $4.07 3/31/202410,200,000 shares $52.43 million +1.3%12.9%6.2 $5.14 3/15/202410,070,000 shares $54.08 million +7.2%12.7%6.1 $5.37 2/29/20249,390,000 shares $74.27 million -3.1%12.1%6.1 $7.91 Get the Latest News and Ratings for CRBU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Caribou Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/20249,690,000 shares $67.83 million -4.3%12.5%6.2 $7.00 1/31/202410,120,000 shares $62.04 million +2.6%13.6%6.1 $6.13 1/15/20249,860,000 shares $53.64 million +2.3%13.2%5.6 $5.44 12/31/20239,640,000 shares $55.24 million -3.0%12.9%5.9 $5.73 12/15/20239,940,000 shares $60.53 million +0.5%13.7%6.5 $6.09 11/30/20239,890,000 shares $58.05 million +10.5%13.7%6 $5.87 11/15/20238,950,000 shares $41.80 million -8.5%12.4%5.3 $4.67 10/31/20239,780,000 shares $35.50 million +24.4%12.9%6 $3.63 10/15/20237,860,000 shares $32.93 million -28.9%10.4%5.3 $4.19 9/30/202311,050,000 shares $52.82 million +34.6%14.6%5.7 $4.78 9/15/20238,210,000 shares $48.11 million +20.9%10.8%2.4 $5.86 8/31/20236,790,000 shares $39.99 million -0.7%9.1%2.1 $5.89 8/15/20236,840,000 shares $45.01 million -6.2%9.2%2.2 $6.58 7/31/20237,290,000 shares $52.42 million -11.1%11.4%2.4 $7.19 7/15/20238,200,000 shares $51.66 million +31.8%12.8%2.9 $6.30 6/30/20236,220,000 shares $26.44 million -17.9%11.6%2.6 $4.25 6/15/20237,580,000 shares $34.87 million -4.3%14.2%10.1 $4.60 5/31/20237,920,000 shares $34.93 million +5.6%14.8%13.1 $4.41 5/15/20237,500,000 shares $33.75 million +9.2%14.0%13.9 $4.50 4/30/20236,870,000 shares $29.54 million +22.0%12.8%13.8 $4.30 4/15/20235,630,000 shares $25.79 million +7.9%10.5%11.1 $4.58 3/31/20235,220,000 shares $27.72 million +10.8%9.8%10.9 $5.31 3/15/20234,710,000 shares $24.30 million +10.1%8.8%9.2 $5.16 2/28/20234,280,000 shares $26.07 million -5.5%8.0%8.2 $6.09 2/15/20234,530,000 shares $30.62 million +3.7%8.5%8.4 $6.76 1/31/20234,370,000 shares $31.51 million No Change8.6%8 $7.21 1/15/20234,370,000 shares $31.55 million +14.7%8.6%7.6 $7.22 12/30/20223,810,000 shares $23.93 million +10.4%7.5%6.6 $6.28 12/15/20223,450,000 shares $26.67 million +3.3%6.8%6.1 $7.73 11/30/20223,340,000 shares $31.10 million +1.8%6.6%5.1 $9.31 11/15/20223,280,000 shares $33.13 million -9.4%6.5%4.9 $10.10 10/31/20223,620,000 shares $35.26 million -8.8%7.2%4.8 $9.74 10/15/20223,970,000 shares $37.12 million -1.5%7.8%5.2 $9.35 9/30/20224,030,000 shares $42.52 million +39.9%8.0%5.5 $10.55A Wave of Creative Destruction Set to Strike June 30 (Ad)You have until June 30 … then all hell will begin to break loose… The White House and Goldman Sachs predict generative AI will soon replace up to 300 MILLION jobs — one in every four careers … worldwide.Click here for details. 9/15/20222,880,000 shares $36.84 million +15.2%5.7%3.9 $12.79 8/31/20222,500,000 shares $24.68 million -14.4%4.9%3.3 $9.87 8/15/20222,920,000 shares $29.26 million -24.4%5.8%3.8 $10.02 7/31/20223,860,000 shares $31.34 million +5.8%7.7%4.5 $8.12 7/15/20223,650,000 shares $26.13 million No Change7.3%4.4 $7.16 6/30/20223,650,000 shares $19.82 million +8.0%7.3%4.5 $5.43 6/15/20223,380,000 shares $17.91 million +0.6%6.8%4.3 $5.30 5/31/20223,360,000 shares $27.99 million +33.9%6.7%4.6 $8.33 5/15/20222,510,000 shares $22.51 million +7.7%5.1%3.7 $8.97 4/30/20222,330,000 shares $17.24 million -2.9%4.9%4.4 $7.40 4/15/20222,400,000 shares $19.54 million +1.7%5.0%4.4 $8.14 3/31/20222,360,000 shares $21.66 million +54.3%5.0%3.9 $9.18 3/15/20221,530,000 shares $13.11 million -53.4%3.2%2.5 $8.57 2/28/20223,280,000 shares $32.73 million +7.5%6.9%6.5 $9.98 2/15/20223,050,000 shares $35.35 million +1.3%6.5%6.1 $11.59 1/31/20223,010,000 shares $32.30 million +20.4%6.4%6.5 $10.73 1/15/20222,500,000 shares $29.03 million -5.3%5.3%6 $11.61 12/31/20212,640,000 shares $39.84 million +15.8%5.6%6.8 $15.09 12/15/20212,280,000 shares $38.51 million +18.1%4.8%5.5 $16.89 11/30/20211,930,000 shares $35.88 million +25.3%4.1%3.8 $18.59 11/15/20211,540,000 shares $33.46 million +32.8%3.3%2.7 $21.73 10/29/20211,160,000 shares $25.65 million -9.4%2.5%1.7 $22.11 10/15/20211,280,000 shares $26.68 million -22.4%2.7%1.7 $20.84 9/30/20211,650,000 shares $39.39 million +27.9%3.5%1.7 $23.87 9/15/20211,290,000 shares $35.54 million +29.0%2.8%1.2 $27.55 8/31/20211,000,000 shares $27.20 million +67.0%2.2%0.9 $27.20 8/13/2021598,800 shares $14.51 million No Change1.4%0.5 $24.23 CRBU Short Interest - Frequently Asked Questions What is Caribou Biosciences' current short interest? Short interest is the volume of Caribou Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 10,490,000 shares of CRBU short. 13.13% of Caribou Biosciences' shares are currently sold short. Learn More on Caribou Biosciences' current short interest. What is a good short interest ratio for Caribou Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRBU shares currently have a short interest ratio of 6.0. Learn More on Caribou Biosciences's short interest ratio. Which institutional investors are shorting Caribou Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Caribou Biosciences: PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Caribou Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.13% of Caribou Biosciences' floating shares are currently sold short. Is Caribou Biosciences' short interest increasing or decreasing? Caribou Biosciences saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 10,490,000 shares, a decrease of 1.4% from the previous total of 10,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Caribou Biosciences' float size? Caribou Biosciences currently has issued a total of 90,320,000 shares. Some of Caribou Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Caribou Biosciences currently has a public float of 79,880,000 shares. How does Caribou Biosciences' short interest compare to its competitors? 13.13% of Caribou Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Caribou Biosciences: Monte Rosa Therapeutics, Inc. (5.98%), Foghorn Therapeutics Inc. (5.35%), Cellectis S.A. (0.92%), Vaxart, Inc. (10.52%), Sangamo Therapeutics, Inc. (7.10%), bluebird bio, Inc. (28.90%), Precision BioSciences, Inc. (9.53%), Atara Biotherapeutics, Inc. (9.65%), Kezar Life Sciences, Inc. (5.10%), Scholar Rock Holding Co. (16.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Caribou Biosciences stock? Short selling CRBU is an investing strategy that aims to generate trading profit from Caribou Biosciences as its price is falling. CRBU shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Caribou Biosciences? A short squeeze for Caribou Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRBU, which in turn drives the price of the stock up even further. How often is Caribou Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRBU, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Monte Rosa Therapeutics Short Interest Data Foghorn Therapeutics Short Interest Data Cellectis Short Interest Data Vaxart Short Interest Data Sangamo Therapeutics Short Interest Data bluebird bio Short Interest Data Precision BioSciences Short Interest Data Atara Biotherapeutics Short Interest Data Kezar Life Sciences Short Interest Data Scholar Rock Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRBU) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersWe’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from the...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.